Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on spironolactone for the treatment of schizophrenia
2014-001968-35Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in schizophrenia, sponsored by LMU Klinikum. Started Jan 2015; status: completed.
02
Drugs
spironolactone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2014-001968-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001968-35.